Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy
Affirmative Psychotherapy for Mental Health Issues (EQuIP Trial)
N/A
Recruiting
Led By John E Pachankis, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4-month follow-up, 8-month follow-up, and 12-month follow-up
Awards & highlights
EQuIP Trial Summary
This trial is testing whether a 10-session LGBTQ-affirmative cognitive-behavioral therapy delivered via telehealth can reduce heavy drinking and mental health symptoms in sexual minority women in New York State.
Who is the study for?
This trial is for sexual minority women in New York who speak English, drink heavily according to WHO standards, and have depression or anxiety. They must want to reduce drinking but not be in mental health treatment more than once a month or need detoxification.Check my eligibility
What is being tested?
The study tests a special 10-session LGBTQ-affirmative cognitive-behavioral therapy (CBT) via telehealth against usual LGBTQ-affirmative treatments. It aims to see if this new CBT can better reduce heavy drinking and improve mental health symptoms.See study design
What are the potential side effects?
As the interventions are forms of psychotherapy, there may not be physical side effects like with medication. However, participants might experience emotional discomfort discussing personal issues during sessions.
EQuIP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 4-month follow-up, 8-month follow-up, and 12-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4-month follow-up, 8-month follow-up, and 12-month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Drunk driving
Secondary outcome measures
Mental Depression
Change in Emotion Regulation
EQuIP Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: LGBTQ-affirmative Cognitive Behavioral TherapyExperimental Treatment1 Intervention
Individuals assigned to LGBTQ-affirmative cognitive behavioral therapy will receive 10 weekly individually-delivered sessions, directly after baseline assessment, delivered via telehealth. Based on the Unified Protocol, sessions will address minority stress mechanisms underlying sexual minority women's depression, anxiety, and alcohol abuse.
Group II: LGBTQ-affirmative Treatment-as-UsualActive Control1 Intervention
Individuals assigned to LGBTQ-affirmative Treatment-as-Usual will receive 10 weekly sessions from a therapist at the Institute for Human Identity who will provide their LGBTQ-affirmative therapy services via telehealth.
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,852 Previous Clinical Trials
2,737,991 Total Patients Enrolled
6 Trials studying Alcohol Abuse
1,161 Patients Enrolled for Alcohol Abuse
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
801 Previous Clinical Trials
1,364,835 Total Patients Enrolled
81 Trials studying Alcohol Abuse
28,511 Patients Enrolled for Alcohol Abuse
John E Pachankis, PhDPrincipal InvestigatorYale University
2 Previous Clinical Trials
429 Total Patients Enrolled
1 Trials studying Alcohol Abuse
305 Patients Enrolled for Alcohol Abuse
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am legally required to attend treatment.I am receiving mental health treatment at least once a month.I have had 4 or more drinks in one day at least once a week for the last month.I have undergone cognitive behavioral therapy in the last year.
Research Study Groups:
This trial has the following groups:- Group 1: LGBTQ-affirmative Cognitive Behavioral Therapy
- Group 2: LGBTQ-affirmative Treatment-as-Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts for this experiment still underway?
"The clinical trial in question was last updated 9/16/2022, over a year ago, meaning that it is no longer actively recruiting patients. This is corroborated by the information present on clinicaltrials.gov. There are, however, 60 other trials that are still looking for patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger